From Xinhua, via, Chinaview.com.cn:
China’s pharmaceutical watchdog has warned 16 companies that they risk losing their advertising licenses after they published “illegal” ads that exaggerated the benefits of their products.
The 16 ads for drugs and medical equipment were identified by the State Food and Drug Administration (SFDA) on its website Wednesday.
The listed ads contain “a large amount of unscientific assertion and pledges on the products’ benefits and effects”, which seriously misled customers and violated advertising laws, a SFDA circular said.
The ten ads for drugs and six for medical equipment involved firms in Liaoning, Yunnan, Shanxi, Jilin, Hubei, Shandong, Tibet, Sichuan, Beijing, Heilongjiang, Hebei, and Henan. [Full Text]